Guaifenesin And Dextromethorphan Hydrobromide Tablet
Product Images NDC 57631-013

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin And Dextromethorphan Hydrobromide (NDC 57631-013). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Invatech Pharma Solutions Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (917 01 1)

Label (917 01 1)
This text describes a medication containing Guaifenesin and Dextromethorphan Hydrobromide tablets. Each film-coated tablet contains 400 mg of Guaifenesin USP and 20 mg of Dextromethorphan Hydrobromide USP. The tablets are embossed with "ET16" and come in a batch with a specified manufacturing date and quantity of 26,500 tablets. The expiration date and NDC number are provided. The warning states to keep the medication out of the reach of children and store it at controlled room temperature. The text also indicates that the shipment is intended for further processing, with instructions to repack and label the contents in conformance with regulations. The medication is manufactured by Elysium Pharmaceuticals Ltd. for Invatech Pharma Solutions LLC. A caution note indicates that the product is for further manufacturing, processing, or repacking. Contact information for the manufacturer is provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.